Provider Profile:
Lubina Arjyal, M.D.

• Breast Cancer

School

• B.P. Koirala Institute of Health Sciences

Residency

• Gundersen Health System

Fellowships

• Detroit Medical Center/Wayne State University School of Medicine

Professional Memberships

• American Society of Clinical Oncology
• Michigan Society of Hematology and Oncology
• American College of Physicians
• American Medical Association

• Khan AM, Arjyal L, Shamaileh L, Simon M. Gemcitabine-induced digital ischaemia in a patient withmetastatic breast cancer BMJ Case Reports CP 2022;15:e252083.
• Ghimire S, Ravi S, Budhathoki R,Arjyal L, Hamal S, Bista A, Khadka S, Uprety D. Current understanding and future implications ofsepsis-induced thrombocytopenia. Eur J Haematol. 2021 Mar;106(3):301-305.
• Uprety D, Arjyal L,Vallatharasu Y, Bista A, Borgert A, Fitzsimmons AJ, Parsons BM. Utilization of Surgery and Its Impact onSurvival in Patients With Early Stage Small-cell Lung Cancer in the United States. Clin Lung Cancer.2020 Mar;21(2):186-193.e2.
• Arjyal L. Perioperative Bridging Anticoagulation. Ann Intern Med. 2019Aug 6;171(3):224-225.
• Uprety D, Arjyal L, Vallatharasu Y, Bista A, Wittchow RJ, Marinier DE. DurableResponse After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain Metastasis. Clin Lung Cancer. 2019 Sep;20(5):e552- e554.